• Visitors can check out the Forum FAQ by clicking this link. You have to register before you can post: click the REGISTER link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. View our Forum Privacy Policy.
  • Want to receive the latest contracting news and advice straight to your inbox? Sign up to the ContractorUK newsletter here. Every sign up will also be entered into a draw to WIN £100 Amazon vouchers!

Reply to: ?Good news

Collapse

You are not logged in or you do not have permission to access this page. This could be due to one of several reasons:

  • You are not logged in. If you are already registered, fill in the form below to log in, or follow the "Sign Up" link to register a new account.
  • You may not have sufficient privileges to access this page. Are you trying to edit someone else's post, access administrative features or some other privileged system?
  • If you are trying to post, the administrator may have disabled your account, or it may be awaiting activation.

Previously on "?Good news"

Collapse

  • Paralytic
    replied
    Originally posted by Hobosapien View Post
    They forgot to mention the pill is a suppository.
    At -80C

    Leave a comment:


  • Hobosapien
    replied
    They forgot to mention the pill is a suppository.

    Leave a comment:


  • Dark Black
    replied
    Originally posted by AtW View Post
    Give or take
    Remember to swallow...

    Leave a comment:


  • AtW
    replied
    Originally posted by Paddy View Post
    So if you are offered a prick you will say that you prefer oral.
    Give or take

    Leave a comment:


  • Paddy
    replied
    Originally posted by AtW View Post
    “ Pills could replace Covid jabs with British biotech breakthrough

    Sussex-based IosBio has found a way to turn injected vaccines into tablets and signed a deal with California's ImmunityBio

    Putting Covid vaccines into pills could soon move from dream to reality after a Sussex-based biotech signed an agreement with a US pharmaceutical company to test the technology in clinical trials.

    Burgess Hill-based IosBio has found a way to turn injected vaccines into orally administered tablets. The technology is now being used by ImmunityBio, a Californian company developing a vaccine against Covid after signing a licensing agreement with iosBio.

    Clinical trials in monkeys have shown the oral vaccine made using iosBio technology to be highly effective, while the jab version is already in phase two/three trials.

    The oral vaccine will begin clinical trials on Americans this month and ImmunityBio is applying for regulatory approval to run trials in the UK.“

    Pills could replace Covid jabs with British biotech breakthrough

    So if you are offered a prick you will say that you prefer oral.

    Leave a comment:


  • AtW
    replied
    This new development finally solves the last stumbling block - how to power energy hungry 5G chip inside humans body, the solution was obvious: nuclear powered "tablets"...

    Leave a comment:


  • SueEllen
    replied
    Originally posted by d000hg View Post
    That'll really convince the conspiracists there's no microchip...
    Yet they have mobile phones...


    5G!

    5G!

    Leave a comment:


  • d000hg
    replied
    That'll really convince the conspiracists there's no microchip...

    Leave a comment:


  • AtW
    started a topic ?Good news

    ?Good news

    “ Pills could replace Covid jabs with British biotech breakthrough

    Sussex-based IosBio has found a way to turn injected vaccines into tablets and signed a deal with California's ImmunityBio

    Putting Covid vaccines into pills could soon move from dream to reality after a Sussex-based biotech signed an agreement with a US pharmaceutical company to test the technology in clinical trials.

    Burgess Hill-based IosBio has found a way to turn injected vaccines into orally administered tablets. The technology is now being used by ImmunityBio, a Californian company developing a vaccine against Covid after signing a licensing agreement with iosBio.

    Clinical trials in monkeys have shown the oral vaccine made using iosBio technology to be highly effective, while the jab version is already in phase two/three trials.

    The oral vaccine will begin clinical trials on Americans this month and ImmunityBio is applying for regulatory approval to run trials in the UK.“

    Pills could replace Covid jabs with British biotech breakthrough

Working...
X